Xanthus Pharmaceuticals Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $52.9M

Xanthus Pharmaceuticals General Information

Description

Developer of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.

Contact Information

Website
www.xanthus.com
Formerly Known As
Xanthus Life Sciences
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 300 Technology Square
  • Cambridge, MA 02139
  • United States
+1 (617)
Primary Industry
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • 300 Technology Square
  • Cambridge, MA 02139
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xanthus Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 11-Jun-2008 $52.9M Completed Generating Revenue
4. Later Stage VC 07-Mar-2008 Completed Generating Revenue
3. Later Stage VC 30-Nov-2006 Completed Generating Revenue
2. Early Stage VC 12-Dec-2003 $30.8M $42.8M Completed Product Development
1. Early Stage VC 31-Dec-2001 $12M $12M Completed Product Development
To view Xanthus Pharmaceuticals’s complete valuation and funding history, request access »

Xanthus Pharmaceuticals Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDIB BioScience Venture Management Venture Capital Minority
CDIB Capital Group Asset Manager Minority
GeneChem Venture Capital Minority
Gimv PE/Buyout Minority
HealthCare Ventures Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Xanthus Pharmaceuticals FAQs

  • When was Xanthus Pharmaceuticals founded?

    Xanthus Pharmaceuticals was founded in 2001.

  • Where is Xanthus Pharmaceuticals headquartered?

    Xanthus Pharmaceuticals is headquartered in Cambridge, MA.

  • What industry is Xanthus Pharmaceuticals in?

    Xanthus Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Xanthus Pharmaceuticals a private or public company?

    Xanthus Pharmaceuticals is a Private company.

  • What is the current valuation of Xanthus Pharmaceuticals?

    The current valuation of Xanthus Pharmaceuticals is .

  • What is Xanthus Pharmaceuticals’s current revenue?

    The current revenue for Xanthus Pharmaceuticals is .

  • How much funding has Xanthus Pharmaceuticals raised over time?

    Xanthus Pharmaceuticals has raised $83.8M.

  • Who are Xanthus Pharmaceuticals’s investors?

    CDIB BioScience Venture Management, CDIB Capital Group, GeneChem, Gimv, and HealthCare Ventures are 5 of 12 investors who have invested in Xanthus Pharmaceuticals.

  • When was Xanthus Pharmaceuticals acquired?

    Xanthus Pharmaceuticals was acquired on 11-Jun-2008.

  • Who acquired Xanthus Pharmaceuticals?

    Xanthus Pharmaceuticals was acquired by Sarossa Capital.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process